All Stories

  1. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism

    Article • Expert Review of Cardiovascular Therapy, October 2018, Taylor & Francis

    Gerald Chi, Sadaf Sharfaei, M.D. Farima Kahe